Federal Lawsuit Against the FDA to End Blood Testing Requirement To Provide Clozapine, for Severe Mental Illness

This lawsuit is against the FDA to end the requirement of blood testing before dispensing clozapine. Clozapine is a medicine to help people with severe mental illness that has not responded to other treatments. It is FDA approved to help people with schizophrenia and are suicidal. Many patients who need it refuse it due to the painful required testing. Interrupting treatment because of a lapse in blood testing often results in severe damaging consequences. 

It may be read here:

https://bit.ly/Behar-v-FDA